Patents by Inventor Dawn M. Eberhardt

Dawn M. Eberhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7795496
    Abstract: The present invention provides for methods of producing transgenic avians which may include delivering a heterologous nucleic acid to oviduct tissue of an avian wherein the nucleic acid enters a cell of the oviduct tissue and is expressed.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: September 14, 2010
    Assignee: Synageva BioPharma Corp.
    Inventors: Leandro Christmann, Markley C. Leavitt, Dawn M. Eberhardt, Timalynn M. Matthews
  • Publication number: 20090193534
    Abstract: The present invention provides for methods of producing transgenic avians which may include delivering a heterologous nucleic acid to oviduct tissue of an avian wherein the nucleic acid enters a cell of the oviduct tissue and is expressed.
    Type: Application
    Filed: February 13, 2009
    Publication date: July 30, 2009
    Inventors: Leandro Christmann, Markley C. Leavitt, Dawn M. Eberhardt, Timalynn m. Matthews
  • Publication number: 20090188002
    Abstract: The invention includes avians containing an artificial chromosome in their genome and methods of making the avians.
    Type: Application
    Filed: December 12, 2008
    Publication date: July 23, 2009
    Inventors: Leandro Christmann, Dawn M. Eberhardt, Markley C. Leavitt, Alex J. Harvey
  • Patent number: 7432103
    Abstract: The present invention relates to cells that can be passaged in culture and can be used for, among other things, promoter assays and the production of heterologous proteins.
    Type: Grant
    Filed: February 1, 2008
    Date of Patent: October 7, 2008
    Assignee: AviGentics, Inc.
    Inventors: Jeffrey C. Rapp, Stephen H. Parker, Markley C. Leavitt, Dawn M. Eberhardt, Leandro Christmann, Alex J. Harvey
  • Publication number: 20080145861
    Abstract: The present invention relates to cells that can be passaged in culture and can be used for, among other things, promoter assays and the production of heterologous proteins.
    Type: Application
    Filed: February 1, 2008
    Publication date: June 19, 2008
    Inventors: Jeffrey C. Rapp, Stephen H. Parker, Markley C. Leavitt, Dawn M. Eberhardt, Leandro Christmann, Alex J. Harvey
  • Patent number: 7381712
    Abstract: The present invention provides for methods of producing transgenic avians which may include delivering a heterologous nucleic acid to oviduct tissue of an avian wherein the nucleic acid enters a cell of the oviduct tissue and is expressed.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: June 3, 2008
    Assignee: AviGenics, Inc.
    Inventors: Leandro Christmann, Markley C. Leavitt, Dawn M. Eberhardt, Timalynn M. Matthews
  • Patent number: 7351582
    Abstract: The present invention relates to cells that can be passaged in culture and can be used for, among other things, promoter assays and the production of heterologous proteins.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: April 1, 2008
    Assignee: AviGenics, Inc.
    Inventors: Jeffrey C. Rapp, Stephen H. Parker, Markley C. Leavitt, Dawn M. Eberhardt, Leandro Christmann, Alex J. Harvey
  • Publication number: 20040226057
    Abstract: The present invention provides for methods of producing a transgenic avians which may include delivering a heterologous nucleic acid to oviduct tissue of an avian wherein the nucleic acid enters a cell of the oviduct tissue and is expressed.
    Type: Application
    Filed: May 10, 2004
    Publication date: November 11, 2004
    Inventors: Leandro Christmann, Markley C. Leavitt, Dawn M. Eberhardt, Timalynn M. Matthews
  • Publication number: 20020028849
    Abstract: Disclosed is the use of retinoids such as retinol, all trans retinoic acid, and 9-cis retinoic acid to enhance the success of assisted-reproduction. Administration of retinol to superovulated animals dramatically improved embryo viability and development as well as the pregnancy rates of animals implanted with embryos derived from such animals. Culturing presumptive embryos in vitro in the presence of retinol enhanced development of embryos from the presumptive zygotes compared to presumptive embryos not treated with retinol.
    Type: Application
    Filed: April 17, 2001
    Publication date: March 7, 2002
    Inventors: James D. Godkin, Dawn M. Eberhardt